Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COLLEGIUM PHARMACEUTICAL, INC.

(COLL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

COLLEGIUM PHARMACEUTICAL, INC : Change in Directors or Principal Officers, Other Events (form 8-K)

09/30/2021 | 05:12pm EST

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On September 24, 2021, Dr. Alison Fleming resigned from her positions as Executive Vice President and Chief Technical Officer of Collegium Pharmaceutical, Inc. (the "Company"), effective September 30, 2021. The Company appreciates Dr. Fleming's many years of service and wishes her the best in her future endeavors.


Item 8.01   Other Information


Scott Sudduth, who joined the Company as Vice President, Supply Chain in 2018, has been promoted to succeed Dr. Fleming and will serve as the Company's Executive Vice President, Technical Operations effective October 1, 2021.

© Edgar Online, source Glimpses

All news about COLLEGIUM PHARMACEUTICAL, INC.
12/06Collegium Ranks as a Top Place to Work for 2021 by The Boston Globe
GL
11/15Collegium Pharmaceutical Signs $25 million Share-Repurchase Agreement With Jefferies
MT
11/15Needham Adjusts Price Target on Collegium Pharmaceutical to $28 from $26, Keeps Buy Rat..
MT
11/15Collegium Announces $25 Million Accelerated Share Repurchase Program
AQ
11/12COLLEGIUM PHARMACEUTICAL, INC : Costs Associated with Exit or Disposal Activities (form 8-..
AQ
11/11UPDATE : Collegium to Participate in Upcoming Conferences
GL
11/11UPDATE : Collegium to Participate in Upcoming Conferences
GL
11/11Collegium Participate in Upcoming Conferences
AQ
11/05HC Wainwright Adjusts Collegium Pharmaceutical PT to $26 From $28, Maintains Buy Rating
MT
11/05Needham Adjusts Price Target on Collegium Pharmaceutical to $26 From $32, Maintains Buy..
MT
More news
Analyst Recommendations on COLLEGIUM PHARMACEUTICAL, INC.
More recommendations
Financials (USD)
Sales 2021 332 M - -
Net income 2021 110 M - -
Net Debt 2021 - - -
P/E ratio 2021 6,43x
Yield 2021 -
Capitalization 632 M 632 M -
Capi. / Sales 2021 1,91x
Capi. / Sales 2022 1,82x
Nbr of Employees 234
Free-Float 96,2%
Chart COLLEGIUM PHARMACEUTICAL, INC.
Duration : Period :
Collegium Pharmaceutical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends COLLEGIUM PHARMACEUTICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 18,17 $
Average target price 25,63 $
Spread / Average Target 41,0%
EPS Revisions
Managers and Directors
Joseph J. Ciaffoni President, Chief Executive Officer & Director
Colleen Tupper Chief Financial Officer & Executive Vice President
Michael Thomas Heffernan Chairman
Scott Sudduth Executive Vice President-Technical Operations
Richard Malamut Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
COLLEGIUM PHARMACEUTICAL, INC.-9.29%632
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321